The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Detection of Breast Cancer With Addition of Annual Screening Ultrasound or a Single Screening MRI to Mammography in Women With Elevated Breast Cancer Risk
Open accessAbstract
CONTEXT: Annual ultrasound screening may detect small, node-negative breast cancers that are not seen on mammography. Magnetic resonance imaging (MRI) may reveal additional breast cancers missed by both mammography and ultrasound screening. OBJECTIVE: To determine supplemental cancer detection yield of ultrasound and MRI in women at elevated risk for breast cancer. DESIGN, SETTING, AND PARTICIPANTS: From April 2004-February 2006, 2809 women at 21 sites with elevated cancer risk and dense breasts consented to 3 annual independent screens with mammography and ultrasound in randomized order. After 3 rounds of both screenings, 612 of 703 women who chose to undergo an MRI had complete data. The reference standard was defined as a combination of pathology (biopsy results that showed in situ or infiltrating ductal carcinoma or infiltrating lobular carcinoma in the breast or axillary lymph nodes) and 12-month follow-up. MAIN OUTCOME MEASURES: Cancer detection rate (yield), sensitivity, specificity, positive predictive value (PPV3) of biopsies performed and interval cancer rate. RESULTS: A total of 2662 women underwent 7473 mammogram and ultrasound screenings, 110 of whom had 111 breast cancer events: 33 detected by mammography only, 32 by ultrasound only, 26 by both, and 9 by MRI after mammography plus ultrasound; 11 were not detected by any imaging screen. Among 4814 incidence screens in the second and third years combined, 75 women were diagnosed with cancer. Supplemental incidence-screening ultrasound identified 3.7 cancers per 1000 screens (95% CI, 2.1-5.8; P < .001). Sensitivity for mammography plus ultrasound was 0.76 (95% CI, 0.65-0.85); specificity, 0.84 (95% CI, 0.83-0.85); and PPV3, 0.16 (95% CI, 0.12-0.21). For mammography alone, sensitivity was 0.52 (95% CI, 0.40-0.64); specificity, 0.91 (95% CI, 0.90-0.92); and PPV3, 0.38 (95% CI, 0.28-0.49; P < .001 all comparisons). Of the MRI participants, 16 women (2.6%) had breast cancer diagnosed. The supplemental yield of MRI was 14.7 per 1000 (95% CI, 3.5-25.9; P = .004). Sensitivity for MRI and mammography plus ultrasound was 1.00 (95% CI, 0.79-1.00); specificity, 0.65 (95% CI, 0.61-0.69); and PPV3, 0.19 (95% CI, 0.11-0.29). For mammography and ultrasound, sensitivity was 0.44 (95% CI, 0.20-0.70, P = .004); specificity 0.84 (95% CI, 0.81-0.87; P < .001); and PPV3, 0.18 (95% CI, 0.08 to 0.34; P = .98). The number of screens needed to detect 1 cancer was 127 (95% CI, 99-167) for mammography; 234 (95% CI, 173-345) for supplemental ultrasound; and 68 (95% CI, 39-286) for MRI after negative mammography and ultrasound results. CONCLUSION: The addition of screening ultrasound or MRI to mammography in women at increased risk of breast cancer resulted in not only a higher cancer detection yield but also an increase in false-positive findings. TRIAL REGISTRATION: clinicaltrials.gov Identifier: NCT00072501.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
DeLong, E. R., DeLong, D. M., & Clarke-Pearson, D. L. (1988) · Biometrics · doi:10.2307/2531595 · Cited by 22,649 · cited 1×
“DCIS, nuclear grade 15 (45) 3 (12) 2 (6) 1 (9) 1 (11) 22 (20)”
Statistical Methods for Rates and Proportions
Fleiss, J. L., Levin, B., & Paik, M. C. (2003) · Wiley Series in Probability and Statistics · doi:10.1002/0471445428 · Cited by 18,646
Bootstrap methods: another look at the jackknife
Efron, B. (1979) · The Annals of Statistics · doi:10.1214/aos/1176344552 · Cited by 17,602
American Cancer Society Guidelines for Breast Screening with MRI as an Adjunct to Mammography
Saslow, D., Boetes, C., Burke, W., Harms, S., Leach, M. O., Lehman, C. D., Morris, E., Pisano, E., Schnall, M., Sener, S., et al. (2007) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.57.2.75 · Cited by 2,637
Kolb, T. M., Lichy, J., & Newhouse, J. H. (2002) · Radiology · doi:10.1148/radiol.2251011667 · Cited by 1,718
Berg, W. A. (2008) · JAMA · doi:10.1001/jama.299.18.2151 · Cited by 1,526
Screening for Breast Cancer: An Update for the U.S. Preventive Services Task Force
Nelson, H. D., Tyne, K., Naik, A., Bougatsos, C., Chan, B. K., & Humphrey, L. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-151-10-200911170-00009 · Cited by 1,248
Kuhl, C. K., Schrading, S., Leutner, C. C., Morakkabati-Spitz, N., Wardelmann, E., Fimmers, R., Kuhn, W., & Schild, H. H. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2004.00.4960 · Cited by 1,147
Cited by
Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement
Siu, A. L., & on behalf of the U.S. Preventive Services Task Force (2016) · Annals of Internal Medicine · doi:10.7326/m15-2886 · Cited by 2,094
Screening for Breast Cancer: U.S. Preventive Services Task Force Recommendation Statement
U.S. Preventive Services Task Force* (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-151-10-200911170-00008 · Cited by 1,686
Supplemental MRI Screening for Women with Extremely Dense Breast Tissue
Bakker, M. F., de Lange, S. V., Pijnappel, R. M., Mann, R. M., Peeters, P. H. M., Monninkhof, E. M., Emaus, M. J., Loo, C. E., Bisschops, R. H. C., Lobbes, M. B. I., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1903986 · Cited by 702
Kuhl, C. K., Schrading, S., Strobel, K., Schild, H. H., Hilgers, R.-D., & Bieling, H. B. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.52.5386 · Cited by 679
Deep Convolutional Neural Networks for breast cancer screening
Chougrad, H., Zouaki, H., & Alheyane, O. (2018) · Computer Methods and Programs in Biomedicine · doi:10.1016/j.cmpb.2018.01.011 · Cited by 470
Comstock, C. E., Gatsonis, C., Newstead, G. M., Snyder, B. S., Gareen, I. F., Bergin, J. T., Rahbar, H., Sung, J. S., Jacobs, C., Harvey, J. A., et al. (2020) · JAMA · doi:10.1001/jama.2020.0572 · Cited by 456
Melnikow, J., Fenton, J. J., Whitlock, E. P., Miglioretti, D. L., Weyrich, M. S., Thompson, J. H., & Shah, K. (2016) · Annals of Internal Medicine · doi:10.7326/m15-1789 · Cited by 376
Effects of Age on the Detection and Management of Breast Cancer
McGuire, A., Brown, J., Malone, C., McLaughlin, R., & Kerin, M. (2015) · Cancers · doi:10.3390/cancers7020815 · Cited by 374
Contrast‐enhanced MRI for breast cancer screening
Mann, R. M., Kuhl, C. K., & Moy, L. (2019) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.26654 · Cited by 356
Supplemental Breast MR Imaging Screening of Women with Average Risk of Breast Cancer
Kuhl, C. K., Strobel, K., Bieling, H., Leutner, C., Schild, H. H., & Schrading, S. (2017) · Radiology · doi:10.1148/radiol.2016161444 · Cited by 350
ACR Appropriateness Criteria Breast Cancer Screening
Mainiero, M. B., Lourenco, A., Mahoney, M. C., Newell, M. S., Bailey, L., Barke, L. D., D'Orsi, C., Harvey, J. A., Hayes, M. K., Huynh, P. T., et al. (2013) · Journal of the American College of Radiology · doi:10.1016/j.jacr.2012.09.036 · Cited by 342
Breast Ultrasonography: State of the Art
Hooley, R. J., Scoutt, L. M., & Philpotts, L. E. (2013) · Radiology · doi:10.1148/radiol.13121606 · Cited by 324
Ultrasound as the Primary Screening Test for Breast Cancer: Analysis From ACRIN 6666
Berg, W. A., Bandos, A. I., Mendelson, E. B., Lehrer, D., Jong, R. A., & Pisano, E. D. (2016) · Journal of the National Cancer Institute · doi:10.1093/jnci/djv367 · Cited by 309
Screening Breast Ultrasound: Past, Present, and Future
Brem, R. F., Lenihan, M. J., Lieberman, J., & Torrente, J. (2015) · American Journal of Roentgenology · doi:10.2214/ajr.13.12072 · Cited by 307
Breast Cancer Screening for Women at Higher-Than-Average Risk: Updated Recommendations From the ACR
Monticciolo, D. L., Newell, M. S., Moy, L., Lee, C. S., & Destounis, S. V. (2023) · Journal of the American College of Radiology · doi:10.1016/j.jacr.2023.04.002 · Cited by 290
Breast Cancer Screening and Diagnosis: A Synopsis of the European Breast Guidelines
Schünemann, H. J., Lerda, D., Quinn, C., Follmann, M., Alonso-Coello, P., Rossi, P. G., Lebeau, A., Nyström, L., Broeders, M., Ioannidou-Mouzaka, L., et al. (2020) · Annals of Internal Medicine · doi:10.7326/m19-2125 · Cited by 286
Identifying Women With Dense Breasts at High Risk for Interval Cancer: A Cohort Study
Kerlikowske, K., Zhu, W., Tosteson, A. N. A., Sprague, B. L., Tice, J. A., Lehman, C. D., Miglioretti, D. L., & for the Breast Cancer Surveillance Consortium* (2015) · Annals of Internal Medicine · doi:10.7326/m14-1465 · Cited by 286
Shen, Y., Shamout, F. E., Oliver, J. R., Witowski, J., Kannan, K., Park, J., Wu, N., Huddleston, C., Wolfson, S., Millet, A., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-26023-2 · Cited by 270
Screening for Breast Cancer in 2018—What Should We be Doing Today?
Seely, J. M., & Alhassan, T. (2018) · Current Oncology · doi:10.3747/co.25.3770 · Cited by 258
Qian, X., Pei, J., Zheng, H., Xie, X., Yan, L., Zhang, H., Han, C., Gao, X., Zhang, H., Zheng, W., et al. (2021) · Nature Biomedical Engineering · doi:10.1038/s41551-021-00711-2 · Cited by 253
Ciritsis, A., Rossi, C., Eberhard, M., Marcon, M., Becker, A. S., & Boss, A. (2019) · European Radiology · doi:10.1007/s00330-019-06118-7 · Cited by 117
Huang, Y., Wei, L., Hu, Y., Shao, N., Lin, Y., He, S., Shi, H., Zhang, X., & Lin, Y. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.706733 · Cited by 82
Hsu, J. C., Naha, P. C., Lau, K. C., Chhour, P., Hastings, R., Moon, B. F., Stein, J. M., Witschey, W. R. T., McDonald, E. S., Maidment, A. D. A., et al. (2018) · Nanoscale · doi:10.1039/c8nr03741h · Cited by 63
Pfob, A., Sidey-Gibbons, C., Barr, R. G., Duda, V., Alwafai, Z., Balleyguier, C., Clevert, D.-A., Fastner, S., Gomez, C., Goncalo, M., et al. (2022) · European Journal of Cancer · doi:10.1016/j.ejca.2022.09.018 · Cited by 27
Metadata
- Authors
- Zhang, Z.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2012-04-04
- Volume
- 307
- Issue
- 13
- Pages
- 1394
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W2124653673
- Cited by
- 1,179
- References
- 24
- FWCI
- 56.44
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.